ArticleLeukemia & lymphoma2014

Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia.

Alison R Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.